×
About 698 results

ALLMedicine™ Allergy Immunotherapy Center

Research & Reviews  311 results

Real-world evidence costs of allergic rhinitis and allergy immunotherapy in the commerc...
https://doi.org/10.1080/03007995.2021.1903848
Current Medical Research and Opinion; Tkacz JP, Rance K et. al.

Mar 23rd, 2021 - To assess total and allergic rhinitis (AR)-related healthcare costs among AR patients residing in the United States with a focus on patients persisting with AIT. AR patients were identified in the IBM MarketScan database between 1 January 2014 to ...

Pharmacoeconomics of allergy immunotherapy versus pharmacotherapy.
https://doi.org/10.1080/1744666X.2021.1886079
Expert Review of Clinical Immunology; Cox L

Mar 1st, 2021 - Introduction: The purpose of this review is to evaluate the cost-effectiveness of allergy immunotherapy (AIT) in the treatment of allergic rhinitis, asthma, and other allergic conditions.Area covered: An extensive search of the PubMed and Medline ...

A randomized trial of subcutaneous allergy immunotherapy in inner-city children with as...
https://doi.org/10.1016/j.anai.2020.12.016
Annals of Allergy, Asthma & Immunology : Official Publica... de Vos G, Viswanathan S et. al.

Jan 8th, 2021 - Allergic sensitization to environmental allergens in the first years of life is a strong predictor of asthma morbidity in children. Allergy immunotherapy can improve asthma and allergy outcomes, but its efficacy in inner-city, atopic children of l...

Real-world mapping of allergy immunotherapy in the United States: The argument for impr...
https://doi.org/10.2500/aap.2021.42.200114
Allergy and Asthma Proceedings; Stone B, Rance K et. al.

Dec 28th, 2020 - Background: There is a dearth of real-world evidence studies focused on allergy immunotherapy (AIT) use among patients with allergic rhinitis (AR). Objective: This study examined claims data of AR patients residing in the United States to assess p...

The evolution of allergy immunotherapy.
https://doi.org/10.1016/j.anai.2020.11.011
Annals of Allergy, Asthma & Immunology : Official Publica... Nelson HS

Dec 3rd, 2020 - The objective of this review is to trace the evolution of the art and science of allergy immunotherapy (AIT). Original reports relating to the evolution of the concept of respiratory allergy and its specific treatment were identified by following ...

see more →

Guidelines  3 results

Eosinophilic Asthma | Apfed
https://apfed.org/about-ead/eosinophilic-asthma/

Jun 25th, 2018 - For decades physicians have understood that a diagnosis of asthma requires further description because attacks of wheezing and shortness of breath can be associated with several underlying diseases. For example, patients allergic to animal dander,...

Sublingual immunotherapy A focused allergen immunotherapy practice parameter update
https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Parameters/Sublingual-Immunotherapy-2017.pdf
Greenhawt, M.

Feb 28th, 2017 - The sublingual immunotherapy (SLIT) practice parameterscontain systematically developed statements with recommendationsintended to optimize patient care and assist physicians and/orother health care practitioners and patients to make decisionsrega.

Allergen immunotherapy: A practice parameter third update
https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Parameters/Allergen-immunotherapy-Jan-2011.pdf
Cox, L.

Nov 30th, 2010 - The objective of ‘‘Allergen immunotherapy: a practice parameterthird update’’ is to optimize the practice of allergen immunotherapyfor patients with allergic diseases. This parameter isintended to establish guidelines for the safe and effective us.

see more →

Clinicaltrials.gov  345 results

Real-world evidence costs of allergic rhinitis and allergy immunotherapy in the commerc...
https://doi.org/10.1080/03007995.2021.1903848
Current Medical Research and Opinion; Tkacz JP, Rance K et. al.

Mar 23rd, 2021 - To assess total and allergic rhinitis (AR)-related healthcare costs among AR patients residing in the United States with a focus on patients persisting with AIT. AR patients were identified in the IBM MarketScan database between 1 January 2014 to ...

Pharmacoeconomics of allergy immunotherapy versus pharmacotherapy.
https://doi.org/10.1080/1744666X.2021.1886079
Expert Review of Clinical Immunology; Cox L

Mar 1st, 2021 - Introduction: The purpose of this review is to evaluate the cost-effectiveness of allergy immunotherapy (AIT) in the treatment of allergic rhinitis, asthma, and other allergic conditions.Area covered: An extensive search of the PubMed and Medline ...

A randomized trial of subcutaneous allergy immunotherapy in inner-city children with as...
https://doi.org/10.1016/j.anai.2020.12.016
Annals of Allergy, Asthma & Immunology : Official Publica... de Vos G, Viswanathan S et. al.

Jan 8th, 2021 - Allergic sensitization to environmental allergens in the first years of life is a strong predictor of asthma morbidity in children. Allergy immunotherapy can improve asthma and allergy outcomes, but its efficacy in inner-city, atopic children of l...

Real-world mapping of allergy immunotherapy in the United States: The argument for impr...
https://doi.org/10.2500/aap.2021.42.200114
Allergy and Asthma Proceedings; Stone B, Rance K et. al.

Dec 28th, 2020 - Background: There is a dearth of real-world evidence studies focused on allergy immunotherapy (AIT) use among patients with allergic rhinitis (AR). Objective: This study examined claims data of AR patients residing in the United States to assess p...

The evolution of allergy immunotherapy.
https://doi.org/10.1016/j.anai.2020.11.011
Annals of Allergy, Asthma & Immunology : Official Publica... Nelson HS

Dec 3rd, 2020 - The objective of this review is to trace the evolution of the art and science of allergy immunotherapy (AIT). Original reports relating to the evolution of the concept of respiratory allergy and its specific treatment were identified by following ...

see more →

News  39 results

FDA-Approved Peanut Immunotherapy Protocol Comes With a Cost
https://www.medscape.com/viewarticle/941016

Nov 14th, 2020 - Peanut allergy immunotherapy now comes with approval from the US Food and Drug Administration (FDA), but it also comes with protocols, standards, and paperwork. Whether it will be widely adopted has yet to be determined. A few dozen allergists aro...

Don't Endanger Your Patients: Stop Allergy Immunotherapy Now
https://www.staging.medscape.com/viewarticle/928035

Apr 5th, 2020 - Here in New York City, the US center of the COVID-19 pandemic, I closed my private practice entirely except for telemedicine. In the very early days of this epidemic, I restricted shot hours to avoid overlapping immunotherapy (IT) patients with of...

Don't Endanger Your Patients: Stop Allergy Immunotherapy Now
https://www.medscape.com/viewarticle/928035

Apr 5th, 2020 - Here in New York City, the US center of the COVID-19 pandemic, I closed my private practice entirely except for telemedicine. In the very early days of this epidemic, I restricted shot hours to avoid overlapping immunotherapy (IT) patients with of...

Allergy immunotherapy may modify asthma severity progression
https://www.mdedge.com/chestphysician/article/208885/asthma/allergy-immunotherapy-may-modify-asthma-severity-progression?channel=188
Mark S. Lesney, MDedge News

Sep 26th, 2019 - The use of a grass-based allergy immunotherapy (AIT) lowered the risk of progression from milder to more severe asthma, according to the results of a large, real-world, industry-sponsored, observational study. Photo courtesy Oak Ridge National Lab.

Allergy immunotherapy: Who, what, when … and how safe?
https://www.mdedge.com/pulmonary-health-hub/article/202572/immunology/allergy-immunotherapy-who-what-when-and-how-safe/page/0/2?channel=188

Jun 10th, 2019 - When should you use AIT? Allergic rhinitis (AR). AR can be triggered by exposure to indoor or outdoor inhalant allergens.

see more →